Advanced Biohealing (ABHB) Sees IPO Price of $14 - $16/Share

May 5, 2011 11:32 AM EDT
Get Alerts ABHB Hot Sheet
Trade ABHB Now!
Join SI Premium – FREE
Advanced Biohealing, Inc. (Nasdaq: ABHB) filed an amended registration statement with the U.S. Securities and Exchange Commission today for an Initial Public Offering of its Ordinary Shares. Advanced Biohealing plans to sell 13,350,000 shares and sees an initial price of $14 - $16 per share. Advanced Biohealing has filed to list on the Nasdaq Global Market under the ticker "ABHB."

The offering is being made through BofA/Merrill Lynch, J.P. Morgan, Wells Fargo Securities, William Blair & Co., and Oppenheimer & Co.

Advanced Biohealing is a regenerative medicine company that develops, manufactures and commercializes cell-based therapies.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

William Blair, JPMorgan, Merrill Lynch, Bank of America, Wells Fargo


jay on 2011-05-11 23:11:33
Mark as Spam | Reply to this comment

this is much lower than originally expected

Add Your Comment